Toxicity results of a multicentre randomized phase 3, non-inferiority trial on moderate hypofractionated radiotherapy.

Fonteyne V., Berghen C.B, Van Praet VC,Verbeke S.V.,Villeirs G.V., Vanneste B.V., Ost P.O., De Meerleer G.DM, Lumen N.L.

European Urology Open Science(2023)

引用 0|浏览4
暂无评分
关键词
moderate hypofractionated radiotherapy,non-inferiority
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要